{"brief_title": "Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients", "brief_summary": "To determine the safety and IOP-lowering ability of a test compound in patients with open-angle glaucoma or ocular hypertension.", "condition": ["Open-Angle Glaucoma", "Ocular Hypertension"], "intervention_type": ["Drug"], "intervention_name": ["Glaucoma therapy"], "criteria": "Inclusion Criteria: - Adult subjects of either sex and any race with open-angle glaucoma or ocular hypertension; - logMAR visual acuity not worse than 0.6. Exclusion Criteria: - Clinically relevant ophthalmic or systemic conditions may be excluded.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "POAG", "mesh_term": ["Hypertension", "Glaucoma", "Glaucoma, Open-Angle", "Ocular Hypertension"], "id": "NCT00069719"}